结论CRP水平是临床评估aci患者神经功能缺损程度和近期预后的重要生物学指标。
Conclusion Serum level of CRP is an important biological marker to evaluate the degree of nervous function defect and recent prognosis in ACI.
PSD的发生率和严重程度与神经功能缺损和日常生活能力下降程度有关。
The morbidity and severity of PSD were related to the degrees of neurological impairment and daily living ability decline.
脑梗死可导致不可逆性神经元网络破坏和胶质细胞脱失，并伴有相应神经功能缺损，遗留不同程度的残疾。
Cerebral infarction may result in irreversible neuronal network breakdown and glial cell loss, with stroke-related neurological deficit and remaining different disabilities.
结论巴曲酶能改善、减轻进展性脑梗塞患者神经功能缺损程度和血液流变学，是治疗进展性卒中较理想的药物。
Conclusion Batroxobin can improve and alleviate neuronal deficits and hemorheology of patients with progressive cerebra infarction, it is a better ideal drug for ones.
治疗前后采用脑卒中临床神经功能缺损程度评分量表，肩关节疾患治疗成绩判定标准和手掌手指功能评价进行评判。
Use the measure of nerve function defect grade in the wind stroke, score evaluation of the shoulder disease, hand function evaluation to evaluate the effect of the fore-and-aft the treatment.
PSD的发生率和严重程度与神经功能缺损和日常生活能力下降程度有关。
The incidence and severity of PSD correlated with nerve deficiency and the decrease of ADL.
结果丹奥和葛根素治疗急性脑梗死的临床显效率及神经功能缺损程度评分明显优于对照组（P<0.01）。
Results The effect of ozagrel with puerarin was better in treatment group than that in the control group(P<0.01).
观察治疗前后神经功能缺损程度和舌象变化情况。
The severity of damage in nervous function and changes in tongue lpicture before and after the treatments were observed.
两组治疗前后均进行神经功能缺损程度评分，凝血指标和肝肾功能检查。
Neurological deficit scores, blood clotting index, liver and renal function were examined before and after treatment in both groups.
血清MMP-2和CRP与脑梗死体积、患者神经功能缺损程度呈正相关。
There were obvious positive correlations of MMP-2 and CRP levels to volume of infarct and degree of neurofunction impairment.
血清MMP-2和CRP与脑梗死体积、患者神经功能缺损程度呈正相关。
There were obvious positive correlations of MMP-2 and CRP levels to volume of infarct and degree of neurofunction impairment.
应用推荐